Expanding The Alternatives

While there are many alternatives to traditional therapies for mental health and addictive disorders, uptake has been slow. Less than 60,000 U.S. consumers currently use any prescribed digital therapeutic (see Digital Health Trends 2024). Of U.S. adults receiving treatment for opioid use disorder, 30% receive medications (see Treatment For Opioid Use Disorder: Population Estimates—United States, 2022). Of Medicaid beneficiaries with schizophrenia, the use of long-acting injectable antipsychotics is 15%—less than half of the use in the United Kingdom (see The Underuse Of Clozapine And Long-Acting Injectable Antipsychotics). And between 2017 and 2022, the . . .